Netherlands-based software investor, Main Capital Partners, has made “a substantial investment” in biomedion, a good practice (GxP) data cloud platform provider. biomedion offers an extensive suite of software that is deployed across all GxP areas in the life and health sciences industry, where quality guidelines and regulations are of paramount importance. Headquartered in Berlin, biomedion…
Home Healthcare Markets International Business Germany: Main backs biomedion with substantial investment